Coming May 2025
Get Early Access
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
7.5k employees
MTF, a US-based nonprofit, is committed to providing safe, clinically approved allograft tissue.
HQ
Founded
1987
MTF, a US-based nonprofit, is committed to providing safe, clinically approved allograft tissue. The organization focuses on advancing the science of tissue transplantation to improve patient outcomes. MTF serves medical professionals and patients by offering high-quality, safe tissue grafts for various medical procedures.
MTF has made significant strides in the field of tissue transplantation, impacting countless lives through its dedication to safety and clinical efficacy. The organization collaborates with leading medical institutions and researchers to ensure the highest standards in tissue donation and transplantation.
Operating Status
Active
Main Product(s)
Allograft Tissue
Technology
Biotech
Tags
Healthtech, SaaS
Revenue Type(s)
United States
Customer Type(s)
Non-Profit
When was Musculoskeletal Transplant Foundation founded?
Musculoskeletal Transplant Foundation was founded in 1987.
Where is Musculoskeletal Transplant Foundation's headquarters located?
Musculoskeletal Transplant Foundation's headquarters is located in Edison, NJ, US.
How many employees does Musculoskeletal Transplant Foundation have?
Musculoskeletal Transplant Foundation has 7500 employees as of Feb 4, 2024.
Add Comparison
Current Employees
7.5k
Last updated: Feb 4, 2024
No location information available for this company.
Locations
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts